Clincosm LogoSign in Get a demo

Advanced Malignancies

Showing 26 - 50 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL93)

Recruiting
  • Advanced Malignancies
  • Recombinant Humanized Monoclonal Antibody MIL93
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences and Peking U
Feb 13, 2022

Advanced Malignancies Trial in Japan (Cemiplimab, Ipilimumab, Platinum-doublet chemo)

Recruiting
  • Advanced Malignancies
  • Nagoya, Aichi, Japan
  • +20 more
Jan 7, 2022

Advanced Malignancies Trial in United States (Toripalimab, Recombinant Humanized anti-PD-1 Monoclonal Antibody)

Active, not recruiting
  • Advanced Malignancies
  • Toripalimab, Recombinant Humanized anti-PD-1 Monoclonal Antibody
  • Santa Monica, California
  • +13 more
Dec 12, 2021

Advanced Malignancies Trial in Hangzhou (HRS2300, HRS2300? SHR-1316, HRS2300?SHR-1701)

Recruiting
  • Advanced Malignancies
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Oct 31, 2021

Advanced Malignancies Trial in Shanghai (IBI323)

Recruiting
  • Advanced Malignancies
  • Shanghai, Shanghai, China
    Shang Hai Pulmonary Hospital
Sep 3, 2021

NSCLC, Lung Cancer, Advanced Malignancies Trial in Worldwide (Brigatinib, Crizotinib)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • +3 more
  • Sedona, Arizona
  • +90 more
Jul 27, 2021

Advanced Malignancies, Metastatic Cancer Trial in Los Angeles, Hackensack (INCAGN01876, Epacadostat, Pembrolizumab)

Terminated
Has Results
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +1 more
Jul 1, 2021

Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in Spain, United Kingdom, United States (Azacitidine,

Terminated
Has Results
  • Solid Tumors
  • +2 more
  • Duarte, California
  • +11 more
Apr 13, 2021

Advanced Malignancies, Metastatic Cancer Trial in United States (INCAGN01876)

Completed
Has Results
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +7 more
Feb 9, 2021

Advanced Malignancies Trial in Japan (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Malignancies
  • Cabiralizumab
  • Nivolumab
  • Nagoya-shi, Aichi, Japan
  • +3 more
Nov 24, 2020

Advanced Malignancies, Tumors Trial in La Jolla, Albuquerque, San Antonio (Patupilone/EPO906)

Completed
  • Advanced Malignancies
  • Tumors
  • La Jolla, California
  • +3 more
Dec 6, 2020

Advanced Malignancies, Solid Tumors Trial in San Antonio (Patupilone)

Completed
  • Advanced Malignancies
  • Solid Tumors
  • San Antonio, Texas
    Cancer Therapy and Research Center, Institution for Drug Develop
Dec 6, 2020

Advanced Malignancies Trial in Beijing (SHR-1501)

Unknown status
  • Advanced Malignancies
  • Beijing, China
    Cancer hospital, Chinese academy of medical sciences
Jul 21, 2020

Advanced Malignancies, Urothelial Carcinoma, MSI-H or dMMR Solid Tumors Trial in Salt Lake City (Apatinib, Pembrolizumab)

Terminated
  • Advanced Malignancies
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jul 13, 2020

Advanced Malignancies Trial in Chongqing (TQB3455)

Unknown status
  • Advanced Malignancies
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Jun 30, 2020

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01949)

Completed
Has Results
  • Advanced Malignancies
  • Metastatic Cancer
  • New Brunswick, New Jersey
  • +7 more
May 6, 2020

Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in United States (INCB052793, gemcitabine, nab-paclitaxel)

Terminated
Has Results
  • Solid Tumors
  • +2 more
  • Birmingham, Alabama
  • +13 more
Apr 6, 2020

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Advanced Malignancies Trial in Barcelona, Valencia (alisertib)

Completed
Has Results
  • Advanced Malignancies
  • Barcelona, Spain
  • +1 more
Nov 29, 2018

Advanced Malignancies Trial in Nashville (Alisertib)

Completed
Has Results
  • Advanced Malignancies
  • Nashville, Tennessee
    Sarah Cannon Research Institute (SCRI)
Nov 29, 2018

Advanced Malignancies Trial in Nagoya, Kashiwa, Kobe-city (PDR001)

Completed
  • Advanced Malignancies
  • Nagoya, Aichi, Japan
  • +2 more
Jun 6, 2018

NSCLC, Lung Cancer, Advanced Malignancies Trial in La Jolla, Orange, Detroit (Brigatinib)

No longer available
  • Non-small Cell Lung Cancer
  • +3 more
  • La Jolla, California
  • +2 more
Feb 5, 2018

Advanced Malignancies Trial in United States (MEDI0680 (AMP-514))

Completed
  • Advanced Malignancies
  • MEDI0680 (AMP-514)
  • New Haven, Connecticut
  • +5 more
Oct 4, 2017

Advanced Cancer, Metastatic Cancer, Lymphoma Trial in Canada, United States (CPI-613)

Completed
  • Advanced Cancer
  • +4 more
  • Peoria, Arizona
  • +3 more
Dec 28, 2016

Advanced Malignancies Trial in United States (REGN2810)

Withdrawn
  • Advanced Malignancies
  • Duarte, California
  • +8 more
Nov 4, 2016